NextCell’s phase II study is completed – a phase III is being prepared
NextCell Pharma AB (“NextCell”) announces that the last patient now has left ProTrans-2, meaning the phase II trial with the
Type 1 diabetes treatment with umbilical cord stem cells
NextCell expects ProTrans to be an effective treatment for autoimmune diseases NextCell expects ProTrans to be an effective treatment for
Crown Princess Victoria awards research prize to Cellaviva’s Principal investigator
Cellaviva and NextCell Pharma's Principal investigator receive the award as Child Diabetes Researcher of the Year by Swedish Crown Princess
NextCell Pharma AB publishes prospectus relating to the rights issue and announces the intention of change of listing to Nasdaq First North in July
The Board of Directors of NextCell Pharma AB (“NextCell” or the “Company”) has prepared a prospectus (the “Prospectus”) relating to
Invited to panel discussion; Post-Covid-19 world
NextCell Pharma AB (“NextCell”) has been invited to participate in the panel discussion entitled “The impact of corona virus on
The Board of Directors of NextCell Pharma AB resolves on a fully guaranteed SEK 25.1 million rights issue
NextCell Pharma AB (“NextCell” or the “Company”) announces that the Board of NextCell Pharma AB has resolved to conduct a
Covid-19 study shows the positive effect of treatment with stem cells
First studies testing the effect of mesenchymal stem cells in the treatment of COVID-19 have been published. In this contex, Dr. Leng and colleagues found that a single injection had an effect on 7 patients with COVID-19.
NextCell Pharma AB publishes its interim report for September 2019 – February 2020
NextCell Pharma AB (publ) (NXTCL) today announces that its Interim report for the period September 1, 2019 – February 29,
Covid-19 patients are treated with stem cells
The Corona virus enters the host cell by binding to a receptor on the cells in the blood vessels. The body then responds as soon as the immune system recognizes that there are invaders and sends a number of different cell types and antibodies to try to destroy the virus. The result is a battlefield in every organ affected by the virus, between our immune system and the virus. In the case of COVID-19, the intensity of the battle can trigger a devastating immune reaction.
Why you should consider storage from cord blood
After the birth, the umbilical cord contains the same powerful stem cells that help your baby develop organs, blood, tissue, and an immune system during pregnancy.